Mediwound Ltd Company Profile (NASDAQ:MDWD)

About Mediwound Ltd (NASDAQ:MDWD)

Mediwound Ltd logoMediWound Ltd. is a biopharmaceutical company. The Company focuses on developing, manufacturing and commercializing therapeutics products in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders and other indications. The Company's product, NexoBrid, is indicated for the removal of dead or damaged tissue, known as eschar, in adults with deep partial- and full-thickness thermal burns, also referred to as severe burns. The Company sells NexoBrid in Europe and Israel. NexoBrid is a topically-applied product that removes eschar in four hours without harming the surrounding healthy tissues. Its product, EscharEx, is a topical biological drug, which is being developed for debridement of chronic and other hard-to-heal wounds. NexoBrid and EscharEx are based on its proteolytic enzyme technology. The Company is also developing an injectable product based on its proteolytic enzyme technology for connective tissue pathologies and indications.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Symbol: NASDAQ:MDWD
  • CUSIP: N/A
  • Web: www.mediwound.com
Capitalization:
  • Market Cap: $150.77 million
  • Outstanding Shares: 21,930,000
Average Prices:
  • 50 Day Moving Avg: $6.42
  • 200 Day Moving Avg: $5.82
  • 52 Week Range: $4.25 - $8.58
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -10.11
  • P/E Growth: -0.080
Sales & Book Value:
  • Annual Revenue: $1.84 million
  • Price / Sales: 81.94
  • Book Value: $0.17 per share
  • Price / Book: 39.97
Profitability:
  • EBIDTA: ($19,190,000.00)
  • Net Margins: -1,776.06%
  • Return on Equity: -148.23%
  • Return on Assets: -53.44%
Debt:
  • Current Ratio: 7.55%
  • Quick Ratio: 7.34%
Misc:
  • Average Volume: 38,739 shs.
  • Beta: 0.03
  • Short Ratio: 12.39
 

Frequently Asked Questions for Mediwound Ltd (NASDAQ:MDWD)

What is Mediwound Ltd's stock symbol?

Mediwound Ltd trades on the NASDAQ under the ticker symbol "MDWD."

How were Mediwound Ltd's earnings last quarter?

Mediwound Ltd (NASDAQ:MDWD) posted its quarterly earnings results on Monday, May, 8th. The company reported ($0.20) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.17) by $0.03. The business earned $0.54 million during the quarter, compared to analyst estimates of $0.56 million. Mediwound Ltd had a negative return on equity of 148.23% and a negative net margin of 1,776.06%. The business's revenue for the quarter was up 112.6% on a year-over-year basis. During the same period last year, the company earned ($0.17) EPS. View Mediwound Ltd's Earnings History.

Where is Mediwound Ltd's stock going? Where will Mediwound Ltd's stock price be in 2017?

4 brokers have issued 12 month price objectives for Mediwound Ltd's shares. Their forecasts range from $10.00 to $14.00. On average, they anticipate Mediwound Ltd's share price to reach $12.00 in the next twelve months. View Analyst Ratings for Mediwound Ltd.

Who are some of Mediwound Ltd's key competitors?

Who owns Mediwound Ltd stock?

Mediwound Ltd's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Wellington Management Group LLP (9.84%), Broadfin Capital LLC (2.89%), Massachusetts Financial Services Co. MA (2.25%), California Public Employees Retirement System (0.91%), Morgan Stanley (0.65%) and United Services Automobile Association (0.56%). View Institutional Ownership Trends for Mediwound Ltd.

Who sold Mediwound Ltd stock? Who is selling Mediwound Ltd stock?

Mediwound Ltd's stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, Oppenheimer & Co. Inc., United Services Automobile Association and Massachusetts Financial Services Co. MA. View Insider Buying and Selling for Mediwound Ltd.

Who bought Mediwound Ltd stock? Who is buying Mediwound Ltd stock?

Mediwound Ltd's stock was bought by a variety of institutional investors in the last quarter, including Wellington Management Group LLP, Wells Fargo & Company MN and Renaissance Technologies LLC. View Insider Buying and Selling for Mediwound Ltd.

How do I buy Mediwound Ltd stock?

Shares of Mediwound Ltd can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Mediwound Ltd stock cost?

One share of Mediwound Ltd stock can currently be purchased for approximately $6.88.

Analyst Ratings

Consensus Ratings for Mediwound Ltd (NASDAQ:MDWD) (?)
Ratings Breakdown: 4 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $12.00 (74.55% upside)

Analysts' Ratings History for Mediwound Ltd (NASDAQ:MDWD)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/8/2017Oppenheimer Holdings Inc.Set Price TargetBuy$10.00LowView Rating Details
11/28/2016AegisInitiated CoverageBuy$11.00N/AView Rating Details
8/17/2016Wells Fargo & CoInitiated CoverageOutperform$14.00N/AView Rating Details
7/29/2016Jefferies Group LLCLower Price TargetBuy$15.00 -> $13.00N/AView Rating Details
4/23/2016Brean CapitalReiterated RatingBuyN/AView Rating Details
3/23/2016SunTrust Banks, Inc.Initiated CoverageBuy$13.00N/AView Rating Details
8/11/2015Credit Suisse Group AGLower Price TargetOutperform$18.00 -> $14.00N/AView Rating Details
(Data available from 5/23/2015 forward)

Earnings

Earnings History for Mediwound Ltd (NASDAQ:MDWD)
Earnings by Quarter for Mediwound Ltd (NASDAQ:MDWD)
Earnings History by Quarter for Mediwound Ltd (NASDAQ:MDWD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/8/20173/31/2017($0.17)($0.20)$0.56 million$0.54 millionViewListenView Earnings Details
2/21/201712/31/2016($0.25)($0.09)$0.73 million$0.43 millionViewListenView Earnings Details
11/14/2016Q316($0.26)($0.26)$0.61 million$0.52 millionViewN/AView Earnings Details
7/28/2016Q216($0.23)($0.34)$0.45 million$3.36 millionViewListenView Earnings Details
4/21/2016Q116($0.24)($0.17)$0.28 million$0.25 millionViewListenView Earnings Details
1/25/2016Q415($0.23)($0.36)$0.40 million$0.27 millionViewListenView Earnings Details
10/27/2015Q315($0.31)($0.17)$0.47 million$334.00 millionViewListenView Earnings Details
8/3/2015Q215($0.26)($0.19)$0.22 million$0.17 millionViewListenView Earnings Details
5/4/2015Q1 2015($0.30)($0.28)$0.18 million$0.07 millionViewListenView Earnings Details
2/12/2015Q4($0.26)($0.33)$0.10 million$0.12 millionViewListenView Earnings Details
11/5/2014Q3($0.25)($0.24)$0.31 million$0.05 millionViewListenView Earnings Details
7/31/2014Q2($0.15)($0.28)$0.19 million$0.89 millionViewListenView Earnings Details
5/2/2014Q1 2014($0.11)($0.05)$0.05 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Mediwound Ltd (NASDAQ:MDWD)
2017 EPS Consensus Estimate: ($0.72)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173($0.19)($0.10)($0.16)
Q2 20173($0.21)($0.13)($0.18)
Q3 20173($0.20)($0.16)($0.18)
Q4 20173($0.21)($0.19)($0.20)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Mediwound Ltd (NASDAQ:MDWD)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Mediwound Ltd (NASDAQ:MDWD)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Mediwound Ltd (NASDAQ:MDWD)
Latest Headlines for Mediwound Ltd (NASDAQ:MDWD)
Source:
DateHeadline
finance.yahoo.com logoMediWound Announces Changes to its Board of Directors
finance.yahoo.com - May 18 at 8:36 AM
americanbankingnews.com logoMediwound Ltd Expected to Post Q3 2017 Earnings of ($0.19) Per Share (MDWD)
www.americanbankingnews.com - May 11 at 9:54 AM
americanbankingnews.com logoQ2 2017 EPS Estimates for Mediwound Ltd (MDWD) Boosted by Jefferies Group
www.americanbankingnews.com - May 11 at 8:14 AM
americanbankingnews.com logoMediwound Ltd to Post Q2 2017 Earnings of ($0.21) Per Share, Oppenheimer Holdings Forecasts (MDWD)
www.americanbankingnews.com - May 11 at 8:12 AM
finance.yahoo.com logoMediWound Ltd. :MDWD-US: Earnings Analysis: Q1, 2017 By the Numbers : May 10, 2017
finance.yahoo.com - May 10 at 12:35 PM
americanbankingnews.com logoMediwound Ltd (MDWD) PT Set at $10.00 by Oppenheimer Holdings Inc.
www.americanbankingnews.com - May 9 at 2:34 PM
finance.yahoo.com logoEdited Transcript of MDWD earnings conference call or presentation 8-May-17 12:30pm GMT
finance.yahoo.com - May 9 at 11:52 AM
americanbankingnews.com logoMediwound Ltd (MDWD) Posts Quarterly Earnings Results, Misses Estimates By $0.03 EPS
www.americanbankingnews.com - May 8 at 8:38 PM
finance.yahoo.com logoMediWound Reports First Quarter 2017 Financial Results
finance.yahoo.com - May 8 at 12:32 PM
finance.yahoo.com logoMediWound reports 1Q loss
finance.yahoo.com - May 8 at 12:32 PM
finance.yahoo.com logoInvestor Network: MediWound Ltd. to Host Earnings Call
finance.yahoo.com - May 8 at 12:32 PM
americanbankingnews.com logoMediwound Ltd (MDWD) Expected to Post Quarterly Sales of $480,000.00
www.americanbankingnews.com - May 7 at 8:38 AM
americanbankingnews.com logo-$0.17 EPS Expected for Mediwound Ltd (MDWD) This Quarter
www.americanbankingnews.com - May 5 at 11:19 AM
streetinsider.com logoMediWound (MDWD) Announces Successful GMP Manufacturing Audit by the Israeli Ministry of Health
www.streetinsider.com - May 3 at 9:27 AM
finance.yahoo.com logoMediWound Announces Successful GMP Manufacturing Audit by the Israeli Ministry of Health
finance.yahoo.com - May 3 at 9:27 AM
americanbankingnews.com logoPositive Media Coverage Likely to Affect Mediwound (MDWD) Share Price
www.americanbankingnews.com - May 3 at 12:12 AM
finance.yahoo.com logoMediWound to Host First Quarter 2017 Financial Results Conference Call on May 8, 2017 at 8:30 a.m. Eastern Time
finance.yahoo.com - May 1 at 12:41 PM
americanbankingnews.com logoSomewhat Positive Media Coverage Somewhat Likely to Impact Mediwound (MDWD) Share Price
www.americanbankingnews.com - April 28 at 1:01 AM
americanbankingnews.com logoMediwound (MDWD) Earns News Impact Rating of 0.31
www.americanbankingnews.com - April 21 at 12:14 AM
americanbankingnews.com logoMediwound Ltd (MDWD) to Release Earnings on Wednesday
www.americanbankingnews.com - April 17 at 9:44 AM
americanbankingnews.com logoMediwound (MDWD) Getting Very Positive Media Coverage, Report Shows
www.americanbankingnews.com - April 16 at 8:14 AM
americanbankingnews.com logoZacks: Analysts Anticipate Mediwound Ltd (MDWD) Will Post Earnings of -$0.17 Per Share
www.americanbankingnews.com - April 14 at 9:22 AM
americanbankingnews.com logoMediwound (MDWD) Receives News Sentiment Rating of 0.31
www.americanbankingnews.com - April 13 at 5:27 PM
americanbankingnews.com logoShort Interest in Mediwound Ltd (MDWD) Declines By 6.8%
www.americanbankingnews.com - April 7 at 8:31 PM
finance.yahoo.com logoMediWound’s NexoBrid® and EscharEx® to be Highlighted in Multiple Presentations at the Symposium on Advanced Wound Care Spring
finance.yahoo.com - March 30 at 6:49 PM
americanbankingnews.com logoMediwound Ltd (MDWD) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - March 29 at 1:22 PM
americanbankingnews.com logoMediwound Ltd (MDWD) Stock Rating Reaffirmed by Oppenheimer Holdings Inc.
www.americanbankingnews.com - March 28 at 7:50 AM
americanbankingnews.com logoMediwound Ltd (MDWD) Given Buy Rating at Oppenheimer Holdings Inc.
www.americanbankingnews.com - March 24 at 10:25 PM
finance.yahoo.com logoMediWound Announces Conference Call and Webcast of “Meet the Experts” Panel Discussion Chaired by SunTrust Robinson Humphrey at the 49th American Burn Association Annual Meeting
finance.yahoo.com - March 17 at 6:39 PM
finance.yahoo.com logoMediWound’s NexoBrid® and EscharEx® to be Highlighted in Presentations at the American Burn Association 49th Annual Meeting
finance.yahoo.com - March 14 at 11:11 AM
finance.yahoo.com logoMediWound to Present at the Oppenheimer 27th Annual Healthcare Conference
finance.yahoo.com - March 13 at 10:24 AM
americanbankingnews.com logoQ1 2017 Earnings Forecast for Mediwound Ltd Issued By SunTrust Banks (MDWD)
www.americanbankingnews.com - March 13 at 10:06 AM
finance.yahoo.com logoCost Analysis Demonstrating Significant Health Care Savings Utilizing NexoBrid® in Burn Management Published in BioMed Research International
finance.yahoo.com - March 3 at 6:30 PM
finance.yahoo.com logo7:04 am MediWound announces outcomes from an independent cost analysis review utilizing NexoBrid in severe burn management compared with standard-of-care in the February edition of BioMedical Research International
finance.yahoo.com - March 3 at 6:30 PM
finance.yahoo.com logoMEDIWOUND LTD. Financials
finance.yahoo.com - February 24 at 7:42 PM
finance.yahoo.com logoEdited Transcript of MDWD earnings conference call or presentation 21-Feb-17 1:30pm GMT
finance.yahoo.com - February 22 at 8:18 AM
us.rd.yahoo.com logoMediWound Reports 2016 Fourth Quarter and Full Year Financial Results
us.rd.yahoo.com - February 21 at 6:25 PM
biz.yahoo.com logoQ4 2016 Mediwound Ltd Earnings Release - 07:00 am ET
us.rd.yahoo.com - February 21 at 6:25 PM
nasdaq.com logoMediWound to Host 2016 Fourth Quarter and Full Year Financial Results Conference Call on February 2
www.nasdaq.com - February 14 at 8:00 PM
finance.yahoo.com logoMediWound to Host 2016 Fourth Quarter and Full Year Financial Results Conference Call on February 21, 2017 at 8:30 a.m. Eastern Time
finance.yahoo.com - February 14 at 8:00 PM
nasdaq.com logoFavorable Results from NexoBrid Phase 2 Pharmacokinetic Clinical Study Support Treatment of Severe
www.nasdaq.com - February 10 at 12:34 AM
us.rd.yahoo.com logoFavorable Results from NexoBrid Phase 2 Pharmacokinetic Clinical Study Support Treatment of Severe Burns Covering up to 30% of Total Body Surface Area
us.rd.yahoo.com - February 9 at 7:29 PM
streetinsider.com logoMediWound (MDWD) Cleared by EMA to Begin Second Stage of Pediatric Phase 3 Study of NexoBrid
www.streetinsider.com - February 8 at 12:49 AM
us.rd.yahoo.com logoMediWound Initiates Second Stage of European Pediatric Phase 3 Study of NexoBrid® Expanding Treatment of Severe Burns to Children Age One to Four
us.rd.yahoo.com - February 6 at 9:58 AM
us.rd.yahoo.com logoMediWound Reports Final Positive Results of Phase 2 Clinical Trial of EscharEx for the Debridement of Chronic and Hard-to-Heal Wounds
us.rd.yahoo.com - January 31 at 7:22 PM
finance.yahoo.com logo4 Drug Stocks Poised to Surprise this Earnings Season
finance.yahoo.com - January 28 at 4:58 AM
us.rd.yahoo.com logoWhy Earnings Season Could Be Great for MediWound (MDWD)
us.rd.yahoo.com - January 21 at 12:16 AM
finance.yahoo.com logoEarnings Estimates Moving Higher for MediWound (MDWD): Time to Buy?
finance.yahoo.com - January 10 at 7:24 PM
us.rd.yahoo.com logoMediWound Granted U.S. Patent for MWPC003 for the Treatment of Connective Tissue Diseases
us.rd.yahoo.com - December 20 at 12:15 PM
us.rd.yahoo.com logo7:02 am MediWound announces USPTO issuance of claims related to its MWPC003 for enzymatic treatment of connective tissue diseases
us.rd.yahoo.com - December 20 at 12:15 PM

Social

Chart

Mediwound Ltd (MDWD) Chart for Tuesday, May, 23, 2017

This page was last updated on 5/23/2017 by MarketBeat.com Staff